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Background & objective
The allergen-induced IgE-mediated effector cell activation
is the key mechanism in acute allergic inflammation. The
aim of this study was to produce human monoclonal IgE
antibodies specific for major allergens and the correspond-
ing allergens to study basophil activation.
Methods
Monoclonal human IgE antibodies specific for the major
birch pollen allergen Bet v 1 and for the major grass pollen
allergen Phl p 5 and the corresponding allergens as well as
a hybrid protein consisting of the Bet v 1 and Phl p 5 aller-
gens were expressed. Using circular dichroism spectro-
scopy we compared the fold of the hybrid protein with
that of the mixture of the two allergens. Rat basophil leu-
kemia cells transfected with the human FcεRI receptor
were then loaded with the monoclonal IgE antibodies or
patients serum containing polyclonal allergen-specific IgE
and then exposed to the allergens and the hybrid protein
to study basophil activation.
Results
We found that basophil activation was obtained with a
mixture of two monoclonal IgE antibodies and the hybrid
protein which increased in magnitude with rising con-
centrations of allergen-specific IgE antibodies. Thus
increases in allergen-specific IgE lead to the release of
larger amounts of mediators. When polyclonal IgE from
allergic patients was used, basophil activation was
obtained already with lower concentrations of the hybrid
protein. An augmentation of the number of IgE epitopes
thus increased the allergenic activity and thus the
“potency” of the allergen. Preliminary titration experi-
ments of the two monoclonal IgE antibodies also
suggested that equimolar concentrations of the IgE anti-
bodies with different specificity were most efficient in
causing basophil activation, most likely due to the forma-
tion of large immune complexes.
Conclusion
Results obtained in our molecular model for human baso-
phil activation show that the levels of allergen-specific IgE
dictate the extent of basophil degranulation and that the
number of IgE epitopes determines the potency of an
allergen to induce degranulation. The model should be
useful to explore the factors determining allergen-induced
basophil activation and to study therapeutic strategies con-
trolling this event. This study was supported by grant
P23318-B11 and in part by grants P23350-B11 and F4605
of the Austrian Science Fund (FWF).
Authors’ details
1Medical University of Vienna, Department of Pathophysiology and Allergy
Research, Vienna, Austria. 2University of Salzburg, Department of Molecular
Biology, Salzburg, Austria.
Published: 17 March 2014
doi:10.1186/2045-7022-4-S2-P20
Cite this article as: Najafi et al.: A molecular model system based on
human monoclonal allergen-specific IgE antibodies to study basophil
activation. Clinical and Translational Allergy 2014 4(Suppl 2):P20.
1Medical University of Vienna, Department of Pathophysiology and Allergy
Research, Vienna, Austria
Full list of author information is available at the end of the article
Najafi et al. Clinical and Translational Allergy 2014, 4(Suppl 2):P20
http://www.ctajournal.com/content/4/S2/P20
© 2014 Najafi et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://
creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
